Impact of COVID-19 Pandemic on Cardiac Electronic Device Management and Role of Remote Monitoring
暂无分享,去创建一个
F. Fedele | C. Lavalle | R. Quaglione | C. Vizza | D. D. Della Rocca | F. Miraldi | A. Piro | P. Severino | M. Mariani | M. Magnocavallo | C. Chimenti | G. Vetta | G. Giunta | M. Di Iorio | A. Bernardini | M. Mei | Martina Di Iorio
[1] É. Marijon,et al. The use of remote monitoring of cardiac implantable devices during the COVID-19 pandemic: an EHRA physician survey , 2021, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[2] C. Lavalle,et al. Home delivery of the communicator for remote monitoring of cardiac implantable devices: A multicenter experience during the covid‐19 lockdown , 2021, Pacing and clinical electrophysiology : PACE.
[3] F. Fedele,et al. Sporadic High Pacing and Shock Impedance at Remote Monitoring in Hybrid Implantable Cardioverter Defibrillators Systems: Clinical Impact and Management. , 2021, Heart rhythm.
[4] C. Albert,et al. Changes in the digital health landscape in cardiac electrophysiology: A pre-and peri-pandemic COVID-19 era survey , 2020, Cardiovascular digital health journal.
[5] D. Lougson,et al. Acute. , 2020, The Manchester medical gazette.
[6] Mario J. Garcia,et al. Evidence of systemic endothelial injury and microthrombosis in hospitalized COVID-19 patients at different stages of the disease , 2020, Journal of Thrombosis and Thrombolysis.
[7] I. Nault,et al. Findings of remote monitoring of implantable cardioverter defibrillators during the COVID‐19 pandemic , 2020, Pacing and clinical electrophysiology : PACE.
[8] J. Burkhardt,et al. Creating a safe workplace by universal testing of SARS-CoV-2 infection in asymptomatic patients and healthcare workers in the electrophysiology units: a multi-center experience , 2020, Journal of Interventional Cardiac Electrophysiology.
[9] G. Boriani,et al. Impact of COVID-19 pandemic on the clinical activities related to arrhythmias and electrophysiology in Italy: results of a survey promoted by AIAC (Italian Association of Arrhythmology and Cardiac Pacing) , 2020, Internal and Emergency Medicine.
[10] Shomoita Sayed. COVID-19 and diabetes; Possible role of polymorphism and rise of telemedicine , 2020, Primary Care Diabetes.
[11] F. Fedele,et al. Management of cardiac implantable electronic device follow‐up in COVID‐19 pandemic: Lessons learned during Italian lockdown , 2020, Journal of cardiovascular electrophysiology.
[12] Dhanunjaya R. Lakkireddy,et al. HRS/EHRA/APHRS/LAHRS/ACC/AHA worldwide practice update for telehealth and arrhythmia monitoring during and after a pandemic , 2020, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[13] Dhanunjaya R. Lakkireddy,et al. HRS/EHRA/APHRS/LAHRS/ACC/AHA worldwide practice update for telehealth and arrhythmia monitoring during and after a pandemic , 2020, Heart Rhythm.
[14] S. Garg,et al. The Silver Lining to COVID-19: Avoiding Diabetic Ketoacidosis Admissions with Telehealth. , 2020, Diabetes technology & therapeutics.
[15] H. Ayatollahi,et al. A Systematic Review of the Effectiveness of Telerehabilitation Interventions for Therapeutic Purposes in the Elderly , 2020, Methods of Information in Medicine.
[16] J. Majersik,et al. Acute neurology during the COVID-19 pandemic , 2020, Neurology.
[17] Ritesh Gupta,et al. Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians , 2020, Diabetes & Metabolic Syndrome: Clinical Research & Reviews.
[18] Dhanunjaya R. Lakkireddy,et al. Guidance for cardiac electrophysiology during the COVID-19 pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, American Heart Associat , 2020, Heart Rhythm.
[19] Reyma Raju,et al. How to protect the protectors: 10 lessons to learn for doctors fighting the COVID-19 coronavirus , 2020, Medical Journal Armed Forces India.
[20] Paul J. Wang,et al. Guidance for Cardiac Electrophysiology During the COVID-19 Pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, American Heart Associat , 2020, Circulation.
[21] J. Hollander,et al. Virtually Perfect? Telemedicine for Covid-19. , 2020, The New England journal of medicine.
[22] J. Burkhardt,et al. Simple Electrocardiogaphic Criteria for Rapid Identification of Wide QRS Complex Tachycardia: the new Limb Lead Algorithm. , 2020, Heart rhythm.
[23] G. Gao,et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019 , 2020, The New England journal of medicine.
[24] N. Mercuri,et al. Feasibility of automated detection of sleep apnea using implantable pacemakers and defibrillators: a comparison with simultaneous polysomnography recording , 2019, Journal of Interventional Cardiac Electrophysiology.
[25] T. Bunch,et al. HRS White Paper on interoperability of data from cardiovascular implantable electronic devices (CIEDs). , 2019, Heart Rhythm.
[26] M. Pombo,et al. Safety and efficiency of a common and simplified protocol for pacemaker and defibrillator surveillance based on remote monitoring only: a long-term randomized trial (RM-ALONE) , 2019, European heart journal.
[27] L. Epstein,et al. Factors Influencing the Decision to Proceed to Firmware Upgrades to Implanted Pacemakers for Cybersecurity Risk Mitigation. , 2018, Circulation.
[28] Wojciech Zareba,et al. 2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry. , 2017, Heart rhythm.
[29] G. Hindricks,et al. Daily remote monitoring of implantable cardioverter-defibrillators: insights from the pooled patient-level data from three randomized controlled trials (IN-TIME, ECOST, TRUST) , 2017, European heart journal.
[30] Yi Zhang,et al. A Multisensor Algorithm Predicts Heart Failure Events in Patients With Implanted Devices: Results From the MultiSENSE Study. , 2017, JACC. Heart failure.
[31] Majid Sarrafzadeh,et al. Effectiveness of Remote Patient Monitoring After Discharge of Hospitalized Patients With Heart Failure: The Better Effectiveness After Transition -- Heart Failure (BEAT-HF) Randomized Clinical Trial. , 2016, JAMA internal medicine.
[32] Renato Pietro Ricci,et al. HRS Expert Consensus Statement on remote interrogation and monitoring for cardiovascular implantable electronic devices. , 2015, Heart rhythm.
[33] G. Mairesse,et al. Implementation and reimbursement of remote monitoring for cardiac implantable electronic devices in Europe: a survey from the health economics committee of the European Heart Rhythm Association. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[34] Yun-kai Zhai,et al. Clinical- and Cost-effectiveness of Telemedicine in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis , 2014, Medicine.
[35] R. Ricci,et al. Implantable cardioverter defibrillator remote monitoring is well accepted and easy to use during long-term follow-up , 2014, Journal of Interventional Cardiac Electrophysiology.
[36] H. Heidbuchel,et al. EuroEco (European Health Economic Trial on Home Monitoring in ICD Patients): a provider perspective in five European countries on costs and net financial impact of follow-up with or without remote monitoring , 2014, European heart journal.
[37] G. Hindricks,et al. Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial , 2014, The Lancet.
[38] A. Natale,et al. Novel Perspectives on Arrhythmia-Induced Cardiomyopathy: Pathophysiology, Clinical Manifestations and an Update on Invasive Management Strategies , 2014, Cardiology in review.
[39] Vivek B. Ajmani,et al. Compliance with Remote Monitoring of ICDS/CRTDS in a Real‐World Population , 2014, Pacing and clinical electrophysiology : PACE.
[40] F. Romeo,et al. Device monitoring of heart failure in cardiac resynchronization therapy device recipients: a single-center experience with a novel multivector impedance monitoring system , 2013, Journal of cardiovascular medicine.
[41] G. Hindricks,et al. Quarterly vs. yearly clinical follow-up of remotely monitored recipients of prophylactic implantable cardioverter-defibrillators: results of the REFORM trial , 2013, European heart journal.
[42] Cristina Masella,et al. CONSORT-EHEALTH Checklist V1.6.2 Report , 2013 .
[43] Dominique Lacroix,et al. Costs of remote monitoring vs. ambulatory follow-ups of implanted cardioverter defibrillators in the randomized ECOST study , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[44] Finn Kensing,et al. Patient satisfaction and suggestions for improvement of remote ICD monitoring , 2012, Journal of Interventional Cardiac Electrophysiology.
[45] F. Romeo,et al. Impact of continuous intracardiac ST-segment monitoring on mid-term outcomes of ICD-implanted patients with coronary artery disease. Early results of a prospective comparison with conventional ICD outcomes , 2011, Heart.
[46] R. Canby,et al. Intrathoracic impedance vs daily weight monitoring for predicting worsening heart failure events: results of the Fluid Accumulation Status Trial (FAST). , 2011, Congestive heart failure.
[47] R. Schweikert,et al. Efficacy and Safety of Automatic Remote Monitoring for Implantable Cardioverter-Defibrillator Follow-Up: The Lumos-T Safely Reduces Routine Office Device Follow-Up (TRUST) Trial , 2010, Circulation.
[48] Renato Pietro Ricci,et al. Long-term patient acceptance of and satisfaction with implanted device remote monitoring. , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[49] Stuti Dang,et al. Evaluating the evidence base for the use of home telehealth remote monitoring in elderly with heart failure. , 2009, Telemedicine journal and e-health : the official journal of the American Telemedicine Association.
[50] Cristina Masella,et al. Remote Monitoring of CRT‐ICD: The Multicenter Italian CareLink Evaluation—Ease of Use, Acceptance, and Organizational Implications , 2008, Pacing and clinical electrophysiology : PACE.
[51] Sanjit Bagchi,et al. Telemedicine in Rural India , 2006, PLoS medicine.
[52] D. Weiss,et al. Remote Monitoring of Implantable Cardioverter Defibrillators: , 2004, Pacing and clinical electrophysiology : PACE.
[53] Jagmeet P. Singh,et al. A Multisensor Algorithm Predicts HeartFailure Events in Patients With Implanted Devices , 2017 .
[54] M. Santini,et al. Economic analysis of remote monitoring of cardiac implantable electronic devices: Results of the Health Economics Evaluation Registry for Remote Follow-up (TARIFF) study. , 2017, Heart rhythm.
[55] Richard L. Verrier,et al. ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiacmonitoring / telemetry , 2017 .
[56] J. Nielsen,et al. ESC Guidelines on cardiac pacing and cardiac resynchronization therapy , 2014 .
[57] S. Harris,et al. Temporomandibular Disorder Training, and Biofeedback in the Management of Relaxation Exercise, Manual Therapy, Electrotherapy, A Systematic Review of the Effectiveness of , 2011 .